Sunday, September 20, 2026

Internationa Flavors & Fragrances Stock Impressive Fall 13% At Session Start On Thursday, Underperforms Market

ViaNews Editorial Team

February 9, 2023

Internationa Flavors & Fragrances Stock  Impressive Fall 13%  At Session Start On Thursday, Underperforms Market

(VIANEWS) - Shares of Internationa Flavors & Fragrances (NYSE: IFF) fell by a staggering 13.72% to $97.01 at 10:08 EST on Thursday, following the last session's downward trend. NYSE is falling 0.54% to $15,934.72, following the last session's downward trend. This seems, as yet, a somewhat bearish trend trading session today.

Internationa Flavors & Fragrances's last close was $112.44, 21.45% below its 52-week high of $143.14.

About Internationa Flavors & Fragrances

International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.

Earnings Per Share

As for profitability, Internationa Flavors & Fragrances has a trailing twelve months EPS of $3.21.

PE Ratio

Internationa Flavors & Fragrances has a trailing twelve months price to earnings ratio of 30.22. Meaning, the purchaser of the share is investing $30.22 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.05%.

Moving Average

Internationa Flavors & Fragrances's worth is way under its 50-day moving average of $108.08 and way under its 200-day moving average of $111.69.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Sep 21, 2022, the estimated forward annual dividend rate is 3.24 and the estimated forward annual dividend yield is 3.38%.

Growth Estimates Quarters

The company's growth estimates for the present quarter is a negative 7.8% and positive 1% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 7.1%, now sitting on 12.63B for the twelve trailing months.

More news about Internationa Flavors & Fragrances (IFF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com